Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Pharmaceuticals (Basel)
2023 Dec 04;1612:. doi: 10.3390/ph16121687.
Show Gene links
Show Anatomy links
Lysicamine Reduces Protein Kinase B (AKT) Activation and Promotes Necrosis in Anaplastic Thyroid Cancer.
Rodrigues MT
,
Michelli APP
,
Caso GF
,
de Oliveira PR
,
Rodrigues-Junior DM
,
Morale MG
,
Machado Júnior J
,
Bortoluci KR
,
Tamura RE
,
da Silva TRC
,
Raminelli C
,
Chau E
,
Godin B
,
Calil-Silveira J
,
Rubio IGS
.
???displayArticle.abstract???
Anaplastic thyroid cancer (ATC) is an aggressive form of thyroid cancer (TC), accounting for 50% of total TC-related deaths. Although therapeutic approaches against TC have improved in recent years, the survival rate remains low, and severe adverse effects are commonly reported. However, unexplored alternatives based on natural compounds, such as lysicamine, an alkaloid found in plants with established cytotoxicity against breast and liver cancers, offer promise. Therefore, this study aimed to explore the antineoplastic effects of lysicamine in papillary TC (BCPAP) and ATC (HTH83 and KTC-2) cells. Lysicamine treatment reduced cell viability, motility, colony formation, and AKT activation while increasing the percentage of necrotic cells. The absence of caspase activity confirmed apoptosis-independent cell death. Necrostatin-1 (NEC-1)-mediated necrosome inhibition reduced lysicamine-induced necrosis in KTC-2, suggesting necroptosis induction via a reactive oxygen species (ROS)-independent mechanism. Additionally, in silico analysis predicted lysicamine target proteins, particularly those related to MAPK and TGF-β signaling. Our study demonstrated lysicamine's potential as an antineoplastic compound in ATC cells with a proposed mechanism related to inhibiting AKT activation and inducing cell death.
Bible,
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.
2021, Pubmed
Bible,
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.
2021,
Pubmed
Bock,
Mitochondria as multifaceted regulators of cell death.
2020,
Pubmed
Cesi,
ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells.
2017,
Pubmed
Chin,
Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer.
2009,
Pubmed
Colella,
Sarcoma Spheroids and Organoids-Promising Tools in the Era of Personalized Medicine.
2018,
Pubmed
Cuny,
RIPK protein kinase family: Atypical lives of typical kinases.
2021,
Pubmed
Della Torre,
The Role of Necroptosis: Biological Relevance and Its Involvement in Cancer.
2021,
Pubmed
Derwahl,
Estrogen and its role in thyroid cancer.
2014,
Pubmed
Espinosa-Diez,
Antioxidant responses and cellular adjustments to oxidative stress.
2015,
Pubmed
Ferreira,
Design of spherically structured 3D in vitro tumor models -Advances and prospects.
2018,
Pubmed
Filipiak-Duliban,
Spheroid Culture Differentially Affects Cancer Cell Sensitivity to Drugs in Melanoma and RCC Models.
2022,
Pubmed
Franceschi,
Iodine intake and thyroid carcinoma--a potential risk factor.
1998,
Pubmed
Fuziwara,
High iodine blocks a Notch/miR-19 loop activated by the BRAF(V600E) oncoprotein and restores the response to TGFβ in thyroid follicular cells.
2014,
Pubmed
Gild,
Multikinase inhibitors in thyroid cancer: timing of targeted therapy.
2021,
Pubmed
Greenspan,
Radiation exposure and thyroid cancer.
1977,
Pubmed
Haugen,
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
2016,
Pubmed
Houten,
Differentiated thyroid carcinoma: An update.
2023,
Pubmed
Häggblad Sahlberg,
Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells.
2017,
Pubmed
Indrayanto,
Validation of in-vitro bioassay methods: Application in herbal drug research.
2021,
Pubmed
Jin,
Synergistic action of a RAF inhibitor and a dual PI3K/mTOR inhibitor in thyroid cancer.
2011,
Pubmed
Jung,
Apomorphine suppresses TNF-α-induced MMP-9 expression and cell invasion through inhibition of ERK/AP-1 signaling pathway in MCF-7 cells.
2017,
Pubmed
Kang,
Antioxidant and anticancer constituents from the leaves of Liriodendron tulipifera.
2014,
Pubmed
Keiser,
Relating protein pharmacology by ligand chemistry.
2007,
Pubmed
Kim,
Lenvatinib Compared with Sorafenib as a First-Line Treatment for Radioactive Iodine-Refractory, Progressive, Differentiated Thyroid Carcinoma: Real-World Outcomes in a Multicenter Retrospective Cohort Study.
2023,
Pubmed
Kim,
Astaxanthin induces NADPH oxidase activation and receptor‑interacting protein kinase 1‑mediated necroptosis in gastric cancer AGS cells.
2021,
Pubmed
Lee,
Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor Therapy.
2022,
Pubmed
Leonard,
3D In Vitro Model for Breast Cancer Research Using Magnetic Levitation and Bioprinting Method.
2016,
Pubmed
Li,
Long-Term Declines of Thyroid Cancer Mortality: An International Age-Period-Cohort Analysis.
2020,
Pubmed
Liu,
Structural and mechanistic bases of the anticancer activity of natural aporphinoid alkaloids.
2013,
Pubmed
Liu,
Antioxidant and anticancer aporphine alkaloids from the leaves of Nelumbo nucifera Gaertn. cv. Rosa-plena.
2014,
Pubmed
Luckett,
Co-inhibition of SMAD and MAPK signaling enhances 124I uptake in BRAF-mutant thyroid cancers.
2021,
Pubmed
Lukowski,
Quantitative evaluation of liposomal doxorubicin and its metabolites in spheroids.
2019,
Pubmed
Madej,
Vemurafenib and Dabrafenib Downregulates RIPK4 Level.
2023,
Pubmed
Malhão,
Cytotoxicity of Seaweed Compounds, Alone or Combined to Reference Drugs, against Breast Cell Lines Cultured in 2D and 3D.
2021,
Pubmed
McIver,
Anaplastic thyroid carcinoma: a 50-year experience at a single institution.
2001,
Pubmed
Mohammed,
Advanced thyroid cancers: new era of treatment.
2014,
Pubmed
Molinaro,
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.
2017,
Pubmed
Morrison,
MAP kinase pathways.
2012,
Pubmed
Nikiforov,
Molecular genetics and diagnosis of thyroid cancer.
2011,
Pubmed
Omar,
Aporphine alkaloids from the leaves of Phoebe grandis (Nees) Mer. (Lauraceae) and their cytotoxic and antibacterial activities.
2013,
Pubmed
Osorio,
Alkaloids with antiprotozoal activity.
2008,
Pubmed
Parmenter,
Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis.
2014,
Pubmed
Perut,
Spheroid-based 3D cell cultures identify salinomycin as a promising drug for the treatment of chondrosarcoma.
2018,
Pubmed
Prasongsook,
Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer.
2017,
Pubmed
Qin,
Facile total synthesis of lysicamine and the anticancer activities of the RuII, RhIII, MnII and ZnII complexes of lysicamine.
2017,
Pubmed
Rodrigues-Junior,
Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity.
2022,
Pubmed
,
Echinobase
Rossini,
Total Syntheses of Aporphine Alkaloids via Benzyne Chemistry: An Approach to the Formation of Aporphine Cores.
2015,
Pubmed
,
Echinobase
Rothenberg,
Redifferentiation of iodine-refractory BRAF V600E-mutant metastatic papillary thyroid cancer with dabrafenib.
2015,
Pubmed
Schmid,
Adiposity and risk of thyroid cancer: a systematic review and meta-analysis.
2015,
Pubmed
Shinohara,
AKT in thyroid tumorigenesis and progression.
2007,
Pubmed
Siegel,
Cancer statistics, 2020.
2020,
Pubmed
Silaghi,
State of the Art in the Current Management and Future Directions of Targeted Therapy for Differentiated Thyroid Cancer.
2022,
Pubmed
Singh,
Recent advances in anti-HIV natural products.
2010,
Pubmed
Smallridge,
Anaplastic thyroid carcinoma: pathogenesis and emerging therapies.
2010,
Pubmed
Souza,
Comparative Assay of 2D and 3D Cell Culture Models: Proliferation, Gene Expression and Anticancer Drug Response.
2018,
Pubmed
Strilic,
Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis.
2016,
Pubmed
Stévigny,
Cytotoxic and antitumor potentialities of aporphinoid alkaloids.
2005,
Pubmed
Tölle,
Three-Dimensional Cell Culture Conditions Affect the Proteome of Cancer-Associated Fibroblasts.
2018,
Pubmed
Wang,
Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma.
2022,
Pubmed
Wang,
What has traditional Chinese medicine delivered for modern medicine?
2018,
Pubmed
Wang,
A novel necroptosis-related gene signature associated with immune landscape for predicting the prognosis of papillary thyroid cancer.
2022,
Pubmed
Ware,
Generation of Homogenous Three-Dimensional Pancreatic Cancer Cell Spheroids Using an Improved Hanging Drop Technique.
2016,
Pubmed
Wirth,
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.
2020,
Pubmed
Wong,
PI3K/mTOR inhibition potentiates and extends palbociclib activity in anaplastic thyroid cancer.
2019,
Pubmed
Yi,
Inhibition of the AKT/mTOR Pathway Augments the Anticancer Effects of Sorafenib in Thyroid Cancer.
2017,
Pubmed
Yi,
Downregulation of RIPK4 Expression Inhibits Epithelial-Mesenchymal Transition in Ovarian Cancer through IL-6.
2021,
Pubmed
Yoo,
Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer.
2019,
Pubmed
Yu,
Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanism.
2000,
Pubmed
Yu,
PI3K/mTORC2 regulates TGF-β/Activin signalling by modulating Smad2/3 activity via linker phosphorylation.
2015,
Pubmed
Zaballos,
Key signaling pathways in thyroid cancer.
2017,
Pubmed
Zhang,
Critical protein GAPDH and its regulatory mechanisms in cancer cells.
2015,
Pubmed
Zoetemelk,
Short-term 3D culture systems of various complexity for treatment optimization of colorectal carcinoma.
2019,
Pubmed
